Well Referenced

Tag: PSA Monitoring

Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy

This observational study examined the effects of testosterone replacement therapy (TRT) on prostate-specific antigen (PSA) levels and prostate cancer risk in hypogonadal men. The results showed that TRT significantly increased PSA levels, but there was no observed increase in prostate cancer incidence compared to the general population. These findings suggest

Read More »
June 26, 2025 No Comments

Testosterone Therapy Among Prostate Cancer Survivors

This review examines the safety and implications of testosterone therapy (TT) in men with a history of prostate cancer, a population historically advised against TT due to concerns about cancer recurrence. Emerging evidence suggests that TT may be safe for select prostate cancer survivors, particularly those with low-risk disease and

Read More »
June 26, 2025 No Comments

Testosterone therapy and cancer risk

This study examines the relationship between testosterone therapy and cancer risk, particularly its impact on prostate cancer. The findings suggest that testosterone therapy does not increase the risk of prostate cancer recurrence, even in men with high-risk prostate cancer. However, due to the retrospective nature of this and prior studies,

Read More »
June 26, 2025 No Comments